These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 19493123)

  • 1. Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine.
    Marshall H; Ryan P; Roberton D; Beilby J
    J Paediatr Child Health; 2009 May; 45(5):297-303. PubMed ID: 19493123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of varicella vaccine--a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation.
    Marshall H; Ryan P; Roberton D
    Vaccine; 2005 Nov; 23(46-47):5389-97. PubMed ID: 16039020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella vaccination in Australia and New Zealand.
    Macartney KK; Burgess MA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S191-5. PubMed ID: 18419396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using stated preference discrete choice modelling to evaluate the introduction of varicella vaccination.
    Hall J; Kenny P; King M; Louviere J; Viney R; Yeoh A
    Health Econ; 2002 Jul; 11(5):457-65. PubMed ID: 12112494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 2002 United States varicella vaccine shortage and physician recommendations for vaccination.
    Zimmerman RK; Tabbarah M; Bardenheier B; Janosky JE; Troy JA; Raymund M; Yawn BP
    Prev Med; 2005 Aug; 41(2):575-82. PubMed ID: 15917055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The missing link: family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines.
    Taylor KA; Stocks N; Marshall HS
    Vaccine; 2014 Jul; 32(33):4214-9. PubMed ID: 24923639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella vaccination in Australia.
    Macartney KK; Beutels P; McIntyre P; Burgess MA
    J Paediatr Child Health; 2005 Nov; 41(11):544-52. PubMed ID: 16398834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
    Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
    Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of the status of self-paid varicella vaccination among children one to six years of age in Taiwan.
    Liao SL; Huang T; Huang YC; Jiang DD
    J Microbiol Immunol Infect; 2007 Apr; 40(2):112-5. PubMed ID: 17446958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunisation practices in infants born prematurely: neonatologists' survey and clinical audit.
    Crawford NW; Yeo V; Hunt RW; Barfield C; Gelbart B; Buttery JP
    J Paediatr Child Health; 2009 Oct; 45(10):602-9. PubMed ID: 19751374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician attitudes regarding breakthrough varicella disease and a potential second dose of varicella vaccine.
    Davis MM; Marin M; Cowan AE; Guris D; Clark SJ
    Pediatrics; 2007 Feb; 119(2):258-64. PubMed ID: 17272614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peril of the pox. Are primary care providers aware of varicella vaccination guidelines?
    Persaude D; Teape-Humphrey L; Adelstein R; Domb S; Jaakkimainen L
    Can Fam Physician; 2002 Feb; 48():316-23. PubMed ID: 11889891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in varicella vaccine coverage in the absence of public funding.
    Gustafson R; Skowronski DM
    Vaccine; 2005 May; 23(27):3519-25. PubMed ID: 15855010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program?
    Kwong JC; Tanuseputro P; Zagorski B; Moineddin R; Chan KJ
    Vaccine; 2008 Nov; 26(47):6006-12. PubMed ID: 18761386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004.
    Streng A; Seeger K; Grote V; Liese JG
    Vaccine; 2010 Aug; 28(35):5738-45. PubMed ID: 20600490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chickenpox in adults - clinical management.
    Tunbridge AJ; Breuer J; Jeffery KJ;
    J Infect; 2008 Aug; 57(2):95-102. PubMed ID: 18555533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of state policies on vaccine coverage by age 13 in an insured population.
    Olshen E; Mahon BE; Wang S; Woods ER
    J Adolesc Health; 2007 May; 40(5):405-11. PubMed ID: 17448397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation practices of paediatric oncologists: an Australasian survey.
    Crawford NW; Heath JA; Buttery JP
    J Paediatr Child Health; 2007 Sep; 43(9):593-6. PubMed ID: 17608646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.